Pfizer Genotropin Adds Warning, Contraindication For Prader-Willi Patients
Executive Summary
Pfizer Genotropin (somatropin) will be the only growth hormone in the U.S. to carry a warning regarding use in patients with Prader-Willi syndrome, despite FDA's belief that the potential associated adverse events are a class effect for growth hormone